SALT LAKE CITY--(BUSINESS WIRE)--Oct. 18, 2005--USANA Health
Sciences Inc. (NASDAQ: USNA) today announced strong financial results
for the third fiscal quarter of 2005 (ended Oct. 1, 2005). The company
achieved record net sales of $82.2 million, representing growth of 20%
in the third quarter, compared with $68.7 million in the third quarter
of 2004. These third quarter results were driven both by strong net
sales growth in the United States and year-over-year net sales growth
in all but one of the company's 12 markets.
Earnings from operations in the third quarter of 2005 grew 20.4%
to $14.6 million, or 17.8% of net sales, compared with $12.1 million,
or 17.7% of net sales, in the third quarter of 2004. The company
achieved record net earnings in the third quarter of 2005 of $10.0
million, an increase of 25.6%, compared with net earnings of $8.0
million in the third quarter of 2004. Earnings per share in the third
quarter of 2005 increased to $0.51 per share, an increase of 31%,
compared with $0.39 per share in the third quarter of 2004. During the
third quarter of 2005, the company's estimated tax rate was adjusted
on a year-to-date basis to 34%, which is lower than the 35% tax rate
that the company had previously forecasted for the full year. This
lower tax rate increased earnings per share in the quarter by
approximately $0.02 per share.
For the nine-month period ended Oct. 1, 2005, net sales were
$240.8 million, an increase of 21.8%, compared with $197.7 million in
the comparable period of 2004. Earnings from operations for the first
nine months of 2005 were $42.9 million, an increase of 31.5%, compared
with $32.6 million in the comparable period of 2004. The company
achieved net earnings in the first nine months of 2005 of $28.5
million, an increase of 31.9%, compared with net earnings of $21.6
million in the comparable period of 2004. Earnings per share increased
37.1% in the first nine months of 2005 to $1.44, compared with $1.05
in the comparable period of 2004.
"During the third quarter, we continued to grow sales and
earnings, driven partially by the strength of our sold-out Annual
International Convention in September," said Dave Wentz, president of
USANA. "During the convention, we introduced several new products and
sales tools, including our RESET(TM) Weight Management Program, which
were well received by our Associates. In addition to RESET, we
introduced a variety of other products and sales tools, including
Nutrimeal(TM) sampling packs, a True Health DVD, and a reformulation
of our Usanimals(TM) children's vitamins.
"Buoyed by the success of the convention, U.S. sales, which
represented nearly 43% of total sales, grew 22% compared with last
year," continued Wentz. "In addition, our year-over-year sales grew in
all but one of our markets, and we achieved double-digit growth in
many of our markets. Mexico remained a strong performer during the
quarter, with sales growth of 52%, compared with last year. Although
the third quarter is typically our slowest quarter of the year, the
number of active Associates increased by 14.4% year over year to
127,000."
Gilbert A. Fuller, USANA's chief financial officer, said, "We
achieved another quarter of strong sales and earnings growth that was
driven by continued growth in our existing markets. Although our third
quarter is customarily our weakest quarter, our sales increased
slightly on a sequential basis and net earnings grew by 5%.
"To update our guidance," Fuller continued, "we expect our net
sales in the fourth quarter of 2005 to be $86 million to $88 million,
an increase of as much as 17.2%, compared with $75.1 million in the
fourth quarter of last year. We also expect our earnings per share in
the fourth quarter of 2005 to be $0.50 to $0.52. These estimates are
based on our assumption that we will obtain approval to open our
planned new market in the fourth quarter of 2005. As a result, we
believe our net sales for the full year will be between $327 million
and $329 million. This represents full-year sales growth between 20%
and 21%, compared with 2004. Finally, we now believe our earnings per
share for 2005 will be between $1.94 and $1.96, representing growth of
28% to 30%, compared with 2004.
"Looking ahead to 2006, we expect to grow net sales between 15%
and 20%, and earnings per share between 15% and 20%. This earnings per
share estimate assumes a tax rate for 2006 of 35.5%, but excludes an
estimated $0.10 per share reduction due to the required expensing of
stock options beginning in 2006," concluded Fuller.
USANA will hold a conference call and webcast to discuss this
announcement with investors on Wednesday, Oct. 19, 2005, at 11 a.m.
EDT. Investors may listen to the call by accessing USANA's Web site at
http://www.usanahealthsciences.com and by clicking on the "Investors"
icon.
About USANA
USANA develops and manufactures high-quality nutritionals,
personal care, and weight management products that are sold directly
to Preferred Customers and Associates throughout the United States,
Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea,
Singapore, Mexico, the Netherlands and the United Kingdom. More
information on USANA can be found at
http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act and Section 21E of the
Securities Exchange Act. Actual results could differ materially from
those projected in these forward-looking statements, which involve a
number of risks and uncertainties, including reliance upon our network
of independent Associates, the governmental regulation of our
products, manufacturing and marketing risks, and uncertainties
associated with our planned international expansion. The contents of
this release should be considered in conjunction with the risk
factors, warnings, and cautionary statements that are contained in our
most recent filings with the Securities and Exchange Commission.
USANA Health Sciences Inc.
Consolidated Statements of Earnings
(in thousands, except per share data)
Quarter Ended Nine Months Ended
---------------------- -----------------------
2-Oct-04 1-Oct-05 2-Oct-04 1-Oct-05
---------- ---------- ---------- -----------
(Unaudited) (Unaudited) (Unaudited) (Unaudited)
Net sales $ 68,673 $ 82,225 $ 197,694 $ 240,818
Cost of sales 16,732 19,760 47,985 57,269
---------- ---------- ---------- -----------
Gross profit 51,941 62,465 149,709 183,549
Operating expenses
Associate incentives 26,210 32,545 75,378 94,006
Selling, general and
administrative 13,141 14,756 40,059 44,773
Research and
development 450 551 1,635 1,839
---------- ---------- ---------- -----------
Earnings from
operations 12,140 14,613 32,637 42,931
Other income (expense) (513) 172 (365) 270
---------- ---------- ---------- -----------
Earnings before
income taxes 11,627 14,785 32,272 43,201
Income taxes 3,631 4,743 10,650 14,688
---------- ---------- ---------- -----------
NET EARNINGS $ 7,996 $ 10,042 $ 21,622 $ 28,513
========== ========== ========== ===========
Earnings per share -
diluted $ 0.39 $ 0.51 $ 1.05 $ 1.44
========== ========== ========== ===========
Weighted average
shares outstanding -
diluted 20,296 19,755 20,557 19,849
========== ========== ========== ===========
USANA Health Sciences Inc.
Consolidated Balance Sheets
(in thousands)
As of As of
1-Jan-05 1-Oct-05
---------- ----------
(Unaudited)
ASSETS
Cash and cash
equivalents $ 15,067 $ 31,321
Inventories 17,722 25,518
Other current assets 8,034 6,611
---------- ----------
Total current assets 40,823 63,450
Property and
equipment, net 23,194 22,737
Goodwill 5,690 5,690
Other assets 1,957 2,864
---------- ----------
Total assets $ 71,664 $ 94,741
========== ==========
LIABILITIES AND STOCKHOLDERS'
EQUITY
Accounts payable $ 5,106 $ 6,938
Other current
liabilities 17,644 19,308
---------- ----------
Total current
liabilities 22,750 26,246
Other long-term
liabilities 1,071 1,495
Stockholders' equity 47,843 67,000
---------- ----------
Total liabilities and
stockholders' equity $ 71,664 $ 94,741
========== ==========
USANA Health Sciences Inc.
Sales by Market
(in thousands)
Quarter Ended
-------------------------------------------
2-Oct-04 1-Oct-05
-------------------- --------------------
(Unaudited) (Unaudited)
Region
United States $ 28,827 42.0% $ 35,181 42.8%
Canada 12,553 18.3% 15,231 18.5%
Australia-New Zealand 9,056 13.2% 11,341 13.8%
Hong Kong 2,837 4.1% 2,971 3.6%
Japan 2,356 3.4% 2,562 3.1%
Taiwan 3,903 5.7% 4,885 6.0%
Korea 1,366 2.0% 1,250 1.5%
Singapore 2,678 3.9% 3,680 4.5%
Mexico 2,268 3.3% 3,449 4.2%
Wasatch 2,829 4.1% 1,675 2.0%
--------- --------- --------- ---------
$ 68,673 100.0% $ 82,225 100.0%
========= ========= ========= =========
Active Associates by Market
As of
-------------------------------------------
2-Oct-04 1-Oct-05
-------------------- --------------------
(Unaudited) (Unaudited)
Region
United States 43,000 38.8% 50,000 39.4%
Canada 21,000 18.9% 21,000 16.5%
Australia-New Zealand 14,000 12.6% 16,000 12.6%
Hong Kong 5,000 4.5% 4,000 3.1%
Japan 5,000 4.5% 4,000 3.1%
Taiwan 8,000 7.2% 13,000 10.3%
Korea 3,000 2.7% 2,000 1.6%
Singapore 6,000 5.4% 9,000 7.1%
Mexico 6,000 5.4% 8,000 6.3%
--------- --------- --------- ---------
111,000 100.0% 127,000 100.0%
========= ========= ========= =========
Active Preferred Customers by Market
As of
-------------------------------------------
2-Oct-04 1-Oct-05
-------------------- --------------------
(Unaudited) (Unaudited)
Region
United States 36,000 60.0% 43,000 63.2%
Canada 16,000 26.6% 17,000 25.0%
Australia-New Zealand 5,000 8.3% 6,000 8.8%
Hong Kong 1,000 1.7% (a) 0.0%
Japan (a) 0.0% 1,000 1.5%
Taiwan 1,000 1.7% (a) 0.0%
Korea (a) 0.0% (a) 0.0%
Singapore (a) 0.0% (a) 0.0%
Mexico 1,000 1.7% 1,000 1.5%
--------- --------- --------- ---------
60,000 100.0% 68,000 100.0%
========= ========= ========= =========
(a) Count of Active Preferred Customers is less than 500.
CONTACT: USANA Health Sciences Inc., Salt Lake City
Riley Timmer, 801-954-7100 (Investor Relations)
investor.relations@us.usana.com
SOURCE: USANA Health Sciences Inc.
|
